Adamas Pharmaceuticals Inc 4
4 · Adamas Pharmaceuticals Inc · Filed Sep 9, 2014
Insider Transaction Report
Form 4
BOOTH RICHARD H
Director
Transactions
- Exercise of In-Money
Common Stock
2014-09-05$4.50/sh+17,778$80,001→ 53,778 total - Exercise of In-Money
Common Stock Warrant
2014-09-05−17,778→ 0 totalExercise: $4.50Exp: 2014-09-25→ Common stock (17,778 underlying)
Footnotes (1)
- [F1]The Common Stock Warrant may be exercised through cash payment of the purchase price or through net exercise before the expiration date.